[1]
S. U. Rehman, Q. Z. L, and W. Z. A., “Risk Evaluation in Routine Pharmacovigilance Activities in SKIMS: Analysis of 3 Years Data”., Int J of Pharmc Res, vol. 5, no. 3, pp. 68–74, Mar. 2015, doi: 10.7439/ijpr.v5i3.1876.